Paul Edward Walker - Insider Trading & Ownership

Entity
Individual
Location
1954 Greenspring Drive, Suite 600, Timonium, MD
Summary
The estimated net worth of Paul Edward Walker is at least $319M dollars as of October 3, 2024. Paul Edward Walker is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. Paul Edward Walker is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $109M. Paul Edward Walker is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.1M. Paul Edward Walker is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $1.92M. Paul Edward Walker is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Paul Edward Walker is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $3.2K.
All Insider Reports
All Insider Reports

Ownership of Paul Edward Walker

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M Jun 28, 2021
SVRA Savara Inc 10%+ Owner $109M Jul 17, 2023
KRRO Korro Bio, Inc. 10%+ Owner $61.1M +$1M +1.66% Apr 22, 2024
TRVI Trevi Therapeutics, Inc. 10%+ Owner $1.92M Apr 11, 2022
MTCR Metacrine, Inc. 10%+ Owner $1.2M Dec 10, 2021
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $3.2K Jun 13, 2023
AKUS Akouos, Inc. 10%+ Owner Nov 30, 2022
ALLK Allakos Inc. Director May 24, 2024
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner May 24, 2022
MBX MBX Biosciences, Inc. 10%+ Owner Sep 16, 2024
NEUE NeueHealth, Inc. 10%+ Owner Oct 1, 2024
TRIL Trillium Therapeutics Inc. Director Nov 17, 2021

Insider Transactions Reported by Paul Edward Walker:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.